{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:14Z","timestamp":1761895874640},"reference-count":32,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.redar.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T22:32:03Z","timestamp":1400193123000},"page":"299-303","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Controversias sobre la utilizaci\u00f3n de las soluciones de almid\u00f3n (hidroxietil-almidones). \u00bfEst\u00e1 contraindicado el uso de hidroxietil-almidones de bajo peso molecular?"],"prefix":"10.1016","volume":"61","author":[{"given":"C.A.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Asuero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.redar.2014.04.002_bib0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/bja\/aer515","article-title":"Revised Starling equation and the glycocalyx model of transvascular fluid exchange: An improved paradigm for prescribing intravenous fluid therapy","volume":"108","author":"Woodcock","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.redar.2014.04.002_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding. Guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.redar.2014.04.002_bib0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/ALN.0b013e3181863117","article-title":"A rational approach to perioperative fluid management","volume":"109","author":"Chappell","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.redar.2014.04.002_bib0020","unstructured":"Powell-Tuck JG, Lobo DN, Allison S, Carlson GL, Gore M, Lewington AJ, et al. British Consensus guidelines on intravenous fluid therapy for adult surgical patients. 2011 [consultado 7 Mar 2011]. Disponible en: http:\/\/www.bapenorguk\/pdfs\/bapen_pubs\/giftasuppdf"},{"key":"10.1016\/j.redar.2014.04.002_bib0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00540-010-1034-y","article-title":"Colloid solutions: A clinical update","volume":"24","author":"Niemi","year":"2010","journal-title":"J Anesth"},{"key":"10.1016\/j.redar.2014.04.002_bib0030","first-page":"1","article-title":"Fluid therapy in critical illness: A special focus on indication, the use of hydroxyethyl starch and its different raw materials","volume":"26","author":"Ertmer","year":"2013","journal-title":"Curr Opin Anesthesiol"},{"key":"10.1016\/j.redar.2014.04.002_bib0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00134-012-2472-9","article-title":"Consensus statement of the ESCIM task force on colloid volume therapy in critically ill patients","volume":"38","author":"Reinhart","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.redar.2014.04.002_bib0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00101-006-1122-4","article-title":"The design of the VISEP trial. Critical appraisal","volume":"56","author":"Zander","year":"2007","journal-title":"Anaesthesist"},{"key":"10.1016\/j.redar.2014.04.002_bib0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.redar.2014.04.002_bib0050","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethil starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.redar.2014.04.002_bib0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation\u2013a systematic review and metaanalysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.redar.2014.04.002_bib0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","article-title":"Fluid resuscitation with 6% hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy","volume":"39","author":"Gattas","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.redar.2014.04.002_bib0065","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","article-title":"Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis","volume":"346","author":"Haase","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.redar.2014.04.002_bib0070","unstructured":"PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl-starch [consultado 14 Jun 2013]. Disponible en: www.ema.europa.eu EMA\/ 349341\/2013."},{"key":"10.1016\/j.redar.2014.04.002_bib0075","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/cc12845","article-title":"Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients-a multidisciplinary statement","volume":"17","author":"Meybohm","year":"2013","journal-title":"Critical Care"},{"key":"10.1016\/j.redar.2014.04.002_bib0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.redar.2014.04.002_bib0085","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/cc12484","article-title":"Fluid balance and urine volume are independent predictors of mortality in acute kidney injury","volume":"17","author":"Teixeira","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.redar.2014.04.002_bib0090","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc11358","article-title":"Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130\/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study","author":"Guidet","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.redar.2014.04.002_bib0095","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/cc11213","article-title":"Fluid management and risk factors for renal dysfunction in patients with severe sepsis and\/or septic shock","volume":"16","author":"Muller","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.redar.2014.04.002_bib0100","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/cc8920","article-title":"Resuscitation with low voume hydroxyethylstarch 130 kDa\/0.4 is not associated with acute kiney injury","volume":"14","author":"Boussekey","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.redar.2014.04.002_bib0105","first-page":"253","article-title":"Fluid therapy in critical illness: A special focus on indication, the use of hydroxyethyl starch and its different raw materials","volume":"26","author":"Ertmer","year":"2013","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.redar.2014.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.redar.2014.04.002_bib0115","doi-asserted-by":"crossref","unstructured":"Perel P, Roberts I, Ker K Colloids versus crystalloids for fluid resuscitation in critically ill patients (Colloids versus crystalloids for fluid resuscitation in critically ill patients (Review). Copyright \u00a9 2013 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd.","DOI":"10.1002\/14651858.CD000567.pub6"},{"key":"10.1016\/j.redar.2014.04.002_bib0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1213\/ANE.0b013e318240d6eb","article-title":"Perioperative fluid management strategies in major surgery: A stratified meta-analysis","volume":"114","author":"Corcoran","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.redar.2014.04.002_bib0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/bja\/aes163","article-title":"Which goal for fluid therapy during colorectal surgery in followed by the best outcome: Near maximal stroke volume or zero fluid balance?","volume":"109","author":"Brandstrup","year":"2012","journal-title":"Br J Anaesthesia"},{"key":"10.1016\/j.redar.2014.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1213\/ANE.0b013e3181eeaae5","article-title":"A systematic review and metaanalysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients","volume":"112","author":"Hamilton","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.redar.2014.04.002_bib0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/bja\/aer229","article-title":"Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma)","volume":"107","author":"James","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.redar.2014.04.002_bib0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","article-title":"Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients","volume":"118","author":"Martin","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.redar.2014.04.002_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1213\/ANE.0b013e31827175da","article-title":"Safety of modern starches used during surgery","volume":"113","author":"Van der Linden Ph","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.redar.2014.04.002_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00000542-200701000-00016","article-title":"Influence of different strategies of volume replacement on the activity of matrix metalloproteinases. An in vitro and in vivo study","volume":"106","author":"Volta","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.redar.2014.04.002_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1213\/ANE.0b013e3182159c15","article-title":"Hydroxyethyl starch (130kD) inhibits Toll-like receptor 4 signaling pathways in rat lungs challenged with lipopolysaccharide","volume":"113","author":"Tian","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.redar.2014.04.002_bib0160","unstructured":"PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients HES will be available in restricted patient populations [consultado 11 Oct 2013]. Disponible en: www.ema.europa.eu EMA 606303."}],"container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034935614001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034935614001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T10:22:39Z","timestamp":1565432559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034935614001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0034935614001200"],"URL":"https:\/\/doi.org\/10.1016\/j.redar.2014.04.002","relation":{},"ISSN":["0034-9356"],"issn-type":[{"value":"0034-9356","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversias sobre la utilizaci\u00f3n de las soluciones de almid\u00f3n (hidroxietil-almidones). \u00bfEst\u00e1 contraindicado el uso de hidroxietil-almidones de bajo peso molecular?","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redar.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedad Espa\u00f1ola de Anestesiolog\u00eda, Reanimaci\u00f3n y Terap\u00e9utica del Dolor. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}